This paper aims to provide professionals working with adolescents with gender-dysphoric feelings practical clinical guidelines for diagnosis and treatment. The different phases of the assessment procedure and treatment process are described. Differential diagnostic considerations and possible psychotherapeutic treatment options are given. Physical interventions, including GnRH analogues to inhibit puberty and cross-sex hormones, are described with consideration of eligibility and readiness issues. We end with discussion of post-treatment evaluation. doi:10.1300/J485v09n03_0
Gender dysphoria (GD) in children and adolescents is a condition that is characterized by an incongr...
It is unclear whether the literature on adolescent gender dysphoria (GD) provides evidence to inform...
Gonadotropin-releasing hormone analogues (GnRHa) are recommended as initial treatment for adolescent...
Adolescents presenting with gender-related concerns are increasingly seeking support from providers ...
It is unclear whether the literature on adolescent gender dysphoria (GD) provides evidence to inform...
Treatment outcome in transsexuals is expected to be more favourable when puberty is suppressed than ...
Gender incongruence (GI) is defined as a condition in which the gender identity of a person does not...
Introduction. Puberty suppression by gonadotropin-releasing hormone analogs (GnRHa) is prescribed to...
Gender dysphoria (GD) refers to persistent discomfort stemming from an incongruence between assigned...
International guidelines recommend the use of Gonadotropin-Releasing Hormone (GnRH) agonists in adol...
Over the past 20 years, the care for transgender adolescents has developed throughout many countries...
Introduction: Puberty suppression by gonadotropin-releasing hormone analogs (GnRHa) is prescribed to...
With the upcoming seventh edition of the Standards of Care (SOC), this article addresses various rel...
There has been a large increase in the number of children and adolescents who question conventiona...
Purpose Despite international guidelines being available, not all gender clinics are able to face ge...
Gender dysphoria (GD) in children and adolescents is a condition that is characterized by an incongr...
It is unclear whether the literature on adolescent gender dysphoria (GD) provides evidence to inform...
Gonadotropin-releasing hormone analogues (GnRHa) are recommended as initial treatment for adolescent...
Adolescents presenting with gender-related concerns are increasingly seeking support from providers ...
It is unclear whether the literature on adolescent gender dysphoria (GD) provides evidence to inform...
Treatment outcome in transsexuals is expected to be more favourable when puberty is suppressed than ...
Gender incongruence (GI) is defined as a condition in which the gender identity of a person does not...
Introduction. Puberty suppression by gonadotropin-releasing hormone analogs (GnRHa) is prescribed to...
Gender dysphoria (GD) refers to persistent discomfort stemming from an incongruence between assigned...
International guidelines recommend the use of Gonadotropin-Releasing Hormone (GnRH) agonists in adol...
Over the past 20 years, the care for transgender adolescents has developed throughout many countries...
Introduction: Puberty suppression by gonadotropin-releasing hormone analogs (GnRHa) is prescribed to...
With the upcoming seventh edition of the Standards of Care (SOC), this article addresses various rel...
There has been a large increase in the number of children and adolescents who question conventiona...
Purpose Despite international guidelines being available, not all gender clinics are able to face ge...
Gender dysphoria (GD) in children and adolescents is a condition that is characterized by an incongr...
It is unclear whether the literature on adolescent gender dysphoria (GD) provides evidence to inform...
Gonadotropin-releasing hormone analogues (GnRHa) are recommended as initial treatment for adolescent...